Maxillary squamous cell carcinoma (MSCC) represents a relatively uncommon subset of head and neck cancers; however, its aggressive nature and propensity for early cervical lymph node involvement ...
MSK radiation oncologist Dr. Nancy Lee helped design the clinical trial showing that immunotherapy given around surgery could reduce recurrence of some head and neck cancers. A phase 3 clinical trial ...
Prognosis is extremely poor for patients with head and neck squamous cell carcinoma (HNSCC), which accounts for around 90% of all head and neck cancer. Especially in the more aggressive subtype of ...
The UN says cervical cancer kills a woman every two minutes and remains the fourth most common cancer in women. Caused ...
Cervical cancer treatment trajectories in a sample of cervical cancer patients in the Democratic Republic of the Congo: A retrospective descriptive study. This is an ASCO Meeting Abstract from the ...
The at-home tests are not yet available, but the U.S. Food and Drug Administration approved two self-swab tests from the ...
A 26-year-old HIV-negative female developed multiple, bilateral lung metastases 1 year after undergoing surgery for squamous-cell carcinoma of the cervix. She is in excellent overall health, PS 0, and ...